$Cassava Sciences (SAVA.US)$ Another Bullish reason to go wi...
$Cassava Sciences (SAVA.US)$ Another Bullish reason to go with Sava's Simufilam is that most trial sites in clinical trial sites tend to dismiss their patients after the trials end and they have collected the data results, almost like discarding lab after they no longer serve their purpose. In Alzheimer's, many of the other ones that have been eventually rejected for Brain Bleeding and death have not received any patient testimony or request to Stay on drug. Not only is Simufilam safe and well tolerated, it has improved cognition, slowed declined on mild patients with 89 percent of patients and trial sites requesting to stay on the drug for extension. SAVA did not just discard AD people like the others, they were compassionate and continue to extend treatment of simufilam to patients after the trials were done. This is not fraud, not a placebo on a debilitating disease. Stock price short manipulation on false narratives. The magnitude of breakthrough will not and too late to be silenced now.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Eric Soucy : could you put the whole article? cause this could be anything, its not even mentionned cassava or sava...
Night Pig : It's not from a specific article. He is giving his opinions on various news that has been released.